Allucent (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 74.23%
- Profit Growth 78.80%
- Ebitda 89.40%
- Net Worth 32.61%
- Total Assets 39.05%
About Allucent (India)
Allucent (India) Private Limited (AIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 November 2002 and has a history of 22 years and two months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Pharm-Olam International (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sivakumar Subramanian and Christopher Brennan serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51397KA2002PTC031282
-
Company No.
031282
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Nov 2002
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Allucent (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivakumar Subramanian
|
Director | 21-Feb-2023 | Current |
Christopher Brennan
|
Director | 27-Sep-2022 | Current |
Financial Performance of Allucent (India).
Allucent (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 74.23% increase. The company also saw a substantial improvement in profitability, with a 78.8% increase in profit. The company's net worth Soared by an impressive increase of 32.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Allucent (India)?
In 2022, Allucent (India) had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Thread Research India Private LimitedChristopher Brennan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Allucent (India)?
Allucent (India) has a workforce of 177 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Allucent (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Allucent (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
